You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Drug-delivering aptamers target leukemia stem cells for one-two knockout punch
- 2. Deep cross entropy fusion for pulmonary nodule classification based on ultrasound Imagery
- 3. Preliminary investigation of gut microbiota and associated metabolic pathways in the pathogenesis of primary central nervous system lymphoma
- 4. Pembrolizumab versus bevacizumab plus modified FOLFOX6 in metastatic MSI-H/dMMR colorectal cancer: a multicenter retrospective study with CT evaluation
- 5. Tocilizumab improves the efficacy of anti-PD-1 in a patient with advanced gastroesophageal junction cancer: a case report
- 6. Longevity Medical Institute™ Integrates OncoSeek® to Launch One of Mexico's Most Advanced Cancer Screening Programs
- 7. In pancreatic cancer, a race against time
- 8. In pancreatic cancer, a race against time
- 9. Cancer-associated fibroblasts: multidimensional players in liver cancer
- 10. Rare case report: primary small-cell neuroendocrine carcinoma of the gallbladder
Last updated at 21:53 GMT
Hot News Makers
Health/Pharma Companies
-
143531.97
-
42204.50
-
18113.19
-
12277.79
-
10649.45
-
9941.48
-
5759.22
-
5540.63
-
5246.89
-
5173.53
Drugs, Treatments, Trials
-
12933.40
-
9245.62
-
8306.86
-
7745.02
-
5827.63
-
4282.59
-
3824.41
-
2816.83
-
2688.38
-
2576.84
Last updated at 21:10 GMT
